e-Drug3D 660 |
cas 66852-54-8 |
CLASS DERMATOLOGICAL |
ROUTE (list) TOPICAL |
PK parameters Solubility INSOLUBLE IN WATER |
Target TARGET GLUCOCORTICOID RECEPTOR |
DrugCentral Glucocorticoid receptor UNIPROT P04150 NR3C1 |
Download SDF file | [(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate Formula: Calculated chemical properties: MW 484.95 NB_atoms 33 XLogP 4.05 PSA 60.33 NB_HD 1 NB_HA 5 fsp3 0.72 Lipinski(0=no;1=yes) 1 |
FDA NDA 019967 (pdf not found) INN (HALOBETASOL PROPIONATE) ULTRAVATE (SUN PHARM INDS INC) APPROVAL= AP YEAR= 1990 DISCONTINUED NDA 019968 (pdf not found) INN (HALOBETASOL PROPIONATE) ULTRAVATE (SUN PHARM INDS INC) APPROVAL= AP YEAR= 1990 NEWMOLECULARENTITY DISCONTINUED NDA 076872 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2004 NDA 076903 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (FOUGERA PHARMS) APPROVAL= AP YEAR= 2004 DISCONTINUED NDA 076994 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (TARO) APPROVAL= AP YEAR= 2004 DISCONTINUED NDA 077001 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (FOUGERA PHARMS) APPROVAL= AP YEAR= 2004 NDA 077123 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2004 NDA 077109 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (COSETTE) APPROVAL= AP YEAR= 2005 NDA 077227 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (TARO) APPROVAL= AP YEAR= 2005 DISCONTINUED NDA 077721 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (COSETTE) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 078162 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (COSETTE) APPROVAL= AP YEAR= 2007 NDA 208183 (pdf not found) INN (HALOBETASOL PROPIONATE) ULTRAVATE (LACER PHARMA) APPROVAL= AP YEAR= 2015 NDA 209978 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (ENCUBE) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 210566 (pdf not found) INN (HALOBETASOL PROPIONATE) LEXETTE (MAYNE PHARMA) APPROVAL= AP YEAR= 2018 NDA 209355 (pdf not found) INN (HALOBETASOL PROPIONATE) BRYHALI (BAUSCH) APPROVAL= AP YEAR= 2018 NDA 209354 (pdf not found) INN (HALOBETASOL PROPIONATE ; TAZAROTENE) DUOBRII (BAUSCH) APPROVAL= AP YEAR= 2019 NDA 211464 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 213560 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (QUAGEN) APPROVAL= AP YEAR= 2020 NDA 215266 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2023 NDA 214285 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PERRIGO ISRAEL) APPROVAL= TA YEAR= 2023 NDA 217190 (pdf not found) INN (HALOBETASOL PROPIONATE ; TAZAROTENE) HALOBETASOL PROPIONATE AND TAZAROTENE (TARO) APPROVAL= AP YEAR= 2025 |
Other links: |